Literature DB >> 11071178

Clopidogrel and thrombotic thrombocytopenic purpura.

G J Hankey1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11071178     DOI: 10.1016/S0140-6736(00)02498-3

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  4 in total

Review 1.  Clopidogrel: a review of its use in the prevention of thrombosis.

Authors:  Greg L Plosker; Katherine A Lyseng-Williamson
Journal:  Drugs       Date:  2007       Impact factor: 9.546

2.  Use of antiplatelet inhibitors in peripheral vascular interventions.

Authors:  S William Stavropoulos; Richard D Shlansky-Goldberg
Journal:  Semin Intervent Radiol       Date:  2005-06       Impact factor: 1.513

3.  Two mechanistic pathways for thienopyridine-associated thrombotic thrombocytopenic purpura: a report from the SERF-TTP Research Group and the RADAR Project.

Authors:  Charles L Bennett; Benjamin Kim; Anaadriana Zakarija; Nicholas Bandarenko; Dilip K Pandey; Charlie G Buffie; June M McKoy; Amul D Tevar; John F Cursio; Paul R Yarnold; Hau C Kwaan; Davide De Masi; Ravindra Sarode; Thomas J Raife; Joseph E Kiss; Dennis W Raisch; Charles Davidson; J Evan Sadler; Thomas L Ortel; X Long Zheng; Seiji Kato; Masanori Matsumoto; Masahito Uemura; Yoshihiro Fujimura
Journal:  J Am Coll Cardiol       Date:  2007-09-04       Impact factor: 24.094

4.  Is clopidogrel superior to aspirin in secondary prevention of vascular disease?

Authors:  Ale Algra; Jan van Gijn
Journal:  Curr Control Trials Cardiovasc Med       Date:  2000
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.